{"schema_version":"secwatch.filing_event.v1","accession":"0001870940-23-000036","form_type":"8-K","ticker":"AIRS","cik":"0001870940","company_name":"Airsculpt Technologies, Inc.","filed_at":"2023-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.943720+00:00","generated_at":"2026-06-11T15:36:56.977847+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"AirSculpt Q2 revenue $55.7M (+12.2% YoY), adjusted EPS $0.13, reaffirms FY guidance","bullets":["Revenue $55.7M (+12.2% YoY); net income $1.8M vs $0.6M prior year.","Diluted adjusted EPS $0.13; GAAP EPS $0.03.","Cases 4,186, up 13.4% YoY; opened 4 centers in 2023, including London.","Adjusted EBITDA $14.6M vs $14.0M prior year.","FY 2023 guidance reaffirmed: revenue $187-192M, Adj. EBITDA $43-45M, 5 center openings."],"urls":{"canonical":"https://secwatch.observer/filing/0001870940-23-000036","json":"https://secwatch.observer/filing/0001870940-23-000036.json","markdown":"https://secwatch.observer/filing/0001870940-23-000036.md","text":"https://secwatch.observer/filing/0001870940-23-000036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1870940/000187094023000036/0001870940-23-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1870940/000187094023000036/airs-20230811.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T15:36:56.977847+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8026e01727fe4d37197d883af182c1478f5af9d1","claim":"Airsculpt Technologies, Inc. reported Six months ended June 30, 2023 results: revenue $101.5 million, net income $1.8 million. Guidance reaffirmed.","evidence_excerpt":"to Date 2023 Results Case volume was 7,826 for year to date 2023, representing growth of 14.3% over the prior year case volume of 6,847. Revenue for 2023 increased by 13.8% to $101.5 million from $89.2 million in the prior year period. Year to date net income/(loss) for 2023 increased to $1.8 million compared to $(0.1) million from the prior year period. For the six","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1870940/000187094023000036/0001870940-23-000036-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Six months ended June 30, 2023"},{"label":"Revenue","value":"$101.5 million"},{"label":"Net income","value":"$1.8 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"8d8c1d014841d8f71da09aa142c1d86d6d2c542f","claim":"Airsculpt Technologies, Inc. reported Full year 2023 results: revenue $187 to $192 million. Guidance reaffirmed.","evidence_excerpt":"full year 2023 revenue and adjusted EBITDA guidance as follows and expects to perform at the higher end of both revenue and Adjusted EBITDA ranges: • Revenues in a range of $187 to $192 million • Adjusted EBITDA in a range of $43 to $45 million • Adjusted EBITDA to cash flow from operations conversion ratio of approximately 65% (1) • Five new center","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1870940/000187094023000036/0001870940-23-000036-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Full year 2023"},{"label":"Revenue","value":"$187 to $192 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"ba56b1ee4c2507657e08279d83cbf421a1602bf9","claim":"Airsculpt Technologies, Inc. reported Three months ended June 30, 2023 results: revenue $55.7 million, net income $1.8 million, EPS $0.03. Guidance reaffirmed.","evidence_excerpt":"today announced results for the second quarter ended June 30, 2023. • Cases increased 13.4% over the prior year period to 4,186 • Revenue increased 12.2% over the prior year to $55.7 million • Net income of $1.8 million for the quarter compared to $0.6 million in the prior year period • Diluted income per share for the quarter of $0.03 • Diluted adjusted net income","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1870940/000187094023000036/0001870940-23-000036-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Three months ended June 30, 2023"},{"label":"Revenue","value":"$55.7 million"},{"label":"Net income","value":"$1.8 million"},{"label":"EPS","value":"$0.03"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}